BioCentury
ARTICLE | Top Story

Novartis picks up Emisphere option

February 17, 2000 8:00 AM UTC

Novartis (SWX:NOVN) exercised its option to acquire exclusive worldwide development and commercialization rights from EMIS to oral salmon calcitonin to treat osteoporosis. The product was formulated u...